Secondary gout arising from an identifiable underlying cause other than renal impairment or drug/toxin exposure, reported when the specific affected joint site is not documented or cannot be determined.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- General
Documentation tips
What should appear in the chart to support M10.40.
Source · Editorial brief grounded in 5 cited references ↓
- Identify and code first the specific underlying condition causing secondary gout (e.g., myeloproliferative disorder, hemolytic anemia, psoriasis) — M10.40 cannot stand alone without that sequencing.
- Document the specific joint and laterality at every encounter; if the joint is known, use a site-specific M10.4x code rather than M10.40.
- Record serum uric acid levels, synovial fluid crystal analysis results, and imaging findings to establish medical necessity and distinguish gout from septic arthritis or pseudogout.
- Note whether the presentation is acute (M10.4x) or chronic (M1A.4x) — chronicity must be explicitly stated by the provider, not inferred by the coder.
- Document any comorbidities that affect gout management — chronic kidney disease, hypertension, obesity — as these support medical necessity for urate-lowering therapy and ancillary services.
Related CPT procedures
Procedure codes commonly billed with M10.40. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M10.40 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Failing to sequence the underlying causative condition first — M10.4 carries a 'Code First' instruction in the tabular list; reversing the sequence triggers medical necessity denials.
- Using M10.40 when the joint is documented — if the provider names any specific joint, drop to the appropriate M10.41–M10.49 code with correct site and laterality characters.
- Confusing M10.40 (other secondary gout, unspecified site) with M10.9 (gout, unspecified) — M10.9 is used when the type of gout itself is unknown; M10.40 is used when the type is known to be 'other secondary' but the site is undocumented.
- Applying M10.40 when gout is drug-induced (M10.2x) or renal-impairment-related (M10.3x) — verify the etiology category before landing on M10.4.
- Not distinguishing acute gout (M10.4x) from chronic gout (M1A.4x) — chronic gout has its own category and distinct reimbursement and care-pathway implications.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M10.40 covers gout that is secondary to a condition other than lead exposure (M10.1x), drug-induced causes (M10.2x), or renal impairment (M10.3x), and where no specific joint site is documented. 'Other secondary' causes include conditions such as myeloproliferative disorders, hemolytic anemias, psoriasis, and similar disorders driving hyperuricemia. Per ICD-10-CM tabular instructions for M10.4, you must code first the associated underlying condition — M10.40 is sequenced after that causative diagnosis.
The 'unspecified site' designation means site documentation is missing or genuinely indeterminate. If the clinician documents a specific joint — ankle, knee, shoulder, wrist, etc. — use the site-specific code in the M10.41–M10.49 range with the appropriate 6th character for laterality (1 = right, 2 = left, 9 = unspecified side). M10.40 should not be a default fallback when laterality is simply undocumented; query the provider or review imaging/exam notes first.
M10.40 groups to MS-DRG 553 (Bone Diseases and Arthropathies with MCC) or 554 (without MCC). For chronic secondary gout, consider whether M1A.4x (chronic gout, other secondary) is more appropriate — the distinction turns on documented chronicity. Do not confuse with M10.9 (gout, unspecified), which covers cases where even the type of gout is unclear.
Sibling codes
Other billable codes under M10.4 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What does 'other secondary' mean in M10.40 — what causes qualify?
02Do I always need to code the underlying condition before M10.40?
03When should I use M10.40 versus M10.9?
04When does secondary gout become chronic and require M1A.4x instead?
05Can M10.40 be used for an acute gout flare presentation?
06What CPT procedures are commonly billed alongside M10.40?
07Is M10.40 valid for outpatient and inpatient billing?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 — code M10.40
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M10-/M10.40
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M10.40
- 04cms.govhttps://www.cms.gov/files/document/fy-2025-icd-10-cm-coding-guidelines.pdf
- 05cms.govhttps://www.cms.gov/medicare/coding-billing/icd-10-codes
Mira AI Scribe
Mira AI Scribe captures the underlying condition driving secondary gout, the specific joint and side, acute versus chronic characterization, serum uric acid values, and crystal analysis or imaging results. That documentation locks the correct sequencing order and prevents downcoding to the unspecified M10.9 or an audit flag for missing 'Code First' compliance.
See how Mira captures M10.40 documentation